» Articles » PMID: 21475251

ICSBP Promoter Methylation in Myelodysplastic Syndromes and Acute Myeloid Leukaemia

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2011 Apr 9
PMID 21475251
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.

Gaillard C, Surianarayanan S, Bentley T, Warr M, Fitch B, Geng H Blood Adv. 2018; 2(19):2462-2466.

PMID: 30266821 PMC: 6177650. DOI: 10.1182/bloodadvances.2018018929.


Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML.

Zhang Z, Zhao L, Wei X, Guo Q, Zhu X, Wei R Oncol Lett. 2018; 16(4):5147-5159.

PMID: 30214614 PMC: 6126153. DOI: 10.3892/ol.2018.9237.


GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.

Katsumura K, Ong I, DeVilbiss A, Sanalkumar R, Bresnick E Cell Rep. 2016; 16(9):2428-41.

PMID: 27545880 PMC: 5154384. DOI: 10.1016/j.celrep.2016.07.058.


Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia.

Musialik E, Bujko M, Kober P, Wypych A, Gawle-Krawczyk K, Matysiak M Blood Res. 2015; 50(1):26-32.

PMID: 25830127 PMC: 4377334. DOI: 10.5045/br.2015.50.1.26.


Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.

Sharma A, Yun H, Jyotsana N, Chaturvedi A, Schwarzer A, Yung E Leukemia. 2014; 29(1):157-68.

PMID: 24957708 DOI: 10.1038/leu.2014.162.